Sai Life Science Ltd. - Research Center

---

Results

• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

20.84

17.66

17.56

17.43

Share application money

-

10.61

8.72

7.06

Preference share capital

-

0.39

0.39

0.39

Reserves & surplus

2,146.62

982.54

864.37

842.64

Loan funds

Secured loans

128.64

710.16

751.32

636.70

Unsecured loans

-

-

-

-

Total

2,296.10

1,721.36

1,642.36

1,504.22

Uses of funds

Fixed assets

Gross block

1,913.22

1,503.89

1,115.75

923.41

Less : revaluation reserve

-

-

-

-

Less : accumulated depreciation

535.71

430.14

258.16

220.97

Net block

1,377.51

1,073.75

857.59

702.44

Capital work-in-progress

124.46

106.90

188.69

192.46

Investments

114.18

80.27

63.56

63.36

Net current assets

Current assets, loans & advances

1,520.51

979.01

996.05

858.22

Less : current liabilities & provisions

840.56

518.56

463.54

312.27

Total net current assets

679.95

460.45

532.52

545.95

Miscellaneous expenses not written

-

-

-

-

Total

2,296.10

1,721.36

1,642.36

1,504.22

Notes:

Book value of unquoted investments

114.18

80.27

63.56

63.36

Market value of quoted investments

-

-

-

-

Contingent liabilities

164.66

83.21

48.28

105.23

Number of equity sharesoutstanding (Lacs)

2084.14

176.63

175.56

174.30